Peer-Reviewed Publications - BostonSight™ PROSE

• Sabesan R, Johns L, Tomashevskaya O, Jacobs DS, Rosenthal P, Yoon G. Wavefront-Guided Scleral Lens Prosthetic Device for Keratoconus. Optom Vis Sci. 2013 Apr;90(4):314-23.
• Gire A, Kwok A, Marx DP. PROSE Treatment for Lagophthalmos and Exposure Keratopathy.  Ophthal Plast Reconstr Surg. 2013 Mar;29(2):e38-40.
• Hussoin T, Le HG, Carrasquillo KG, Johns L, Rosenthal P, Jacobs DS. The Effect of Optic Asphericity on Visual Rehabilitation of Corneal Ectasia with a Prosthetic Device. Eye Contact Lens. 2012
  Sep;38(5):300-5.
• Baran I, Bradley J, Le HG, Alipour F, Rosenthal P, Jacobs DS. PROSE Treatment of Corneal Ectasia. Cont Lens Anterior Eye. 2012 Oct;35(5):222-7.
• Cressey A, Jacobs DS, Carrasquillo KG. Management of vascularized limbal keratitis with prosthetic replacement of the ocular surface system. Eye Contact Lens. 2012 Mar;38(2):137-40.
• Grover S, Jacobs DS, Colby KA. Boston Ocular Surface Prosthesis for persistent epitheliopathy after treatment of conjunctival melanoma. Cornea. 2010 Apr;29(4):459-61.
• Stason WB, Razavi M, Jacobs DS, Shepard DS, Suaya JA, Johns L, Rosenthal P. Clinical benefits of the Boston Ocular Surface Prosthesis. Am J Ophthalmol. 2010 Jan;149(1):54-61. 
• Shepard DS, Razavi M, Stason WB, Jacobs DS, Suaya JA, Cohen M, Rosenthal P. Economic appraisal of the Boston Ocular Surface Prosthesis. Am J Ophthalmol. 2009 Dec;148(6):860-8.e2
• Jacobs DS, Lim M, Carrasquillo KG, Rosenthal P. Bevacizumab for corneal neovascularization. Ophthalmology. 2009;116(3):592-3.
• Lim M, Jacobs DS, Rosenthal P, Carrasquillo KG. The Boston Ocular Surface Prosthesis as a novel drug delivery system for bevacizumab. Semin Ophthalmol. 2009 May-Jun;24(3):149-55.
• Lin SJ, Jacobs DS, Frankenthaler R, Rubin PA. An ocular surface prosthesis as an innovative adjunct in patients with head and neck malignancy. Otolaryngol Head Neck Surg. 2008 Oct;139(4):589-91.
• Jacobs DS. Update on scleral lenses. Curr Opin Ophthalmol. 2008 Jul;19(4):298-301.
• Gungor I, Schor K, Rosenthal P, Jacobs DS. The Boston Scleral Lens in the treatment of pediatric patients. J AAPOS. 2008 Jun;12(3):263-7. 
• Takahide K, Parker PM, Wu M, Hwang WY, Carpenter PA, Moravec C, Stehr B, Martin PJ, Rosenthal P, Forman SJ, Flowers ME. Use of fluid-ventilated, gas-permeable scleral lens for management of severe keratoconjunctivitis sicca secondary to chronic graft-versus-host disease. Biol Blood Marrow Transplant. 2007 Sep;13(9):1016-21.
• Jacobs DS, Rosenthal P. Boston scleral lens prosthetic device for treatment of severe dry eye in chronic graft-versus-host disease. Cornea. 2007 Dec;26(10):1195-9.
• Rosenthal P, Croteau A. Fluid-ventilated, gas-permeable scleral contact lens is an effective option for managing severe ocular surface disease and many corneal disorders that would otherwise require penetrating keratoplasty. Eye Contact Lens. 2005 May;31(3):130
• Rosenthal P, Cotter JM, Baum J. Treatment of persistent corneal epithelial defect with extended wear of a fluid-ventilated gas-permeable scleral contact lens. Am J Ophthalmol. 2000 Jul;130(1):33-41.
• Romero-Rangel T, Stavrou P, Cotter J, Rosenthal P, Baltatzis S, Foster CS. Gas-permeable scleral contact lens therapy in ocular surface disease. Am J Ophthalmol. 2000 Jul;130(1):25-32.
• Cotter JM, Rosenthal P. Scleral contact lenses. J Am Optom Assoc. 1998 Jan;69(1):33-40.
• Rosenthal P, Cotter JM. Clinical performance of a spline-based apical vaulting keratoconus corneal contact lens design. CLAO J. 1995 Jan;21(1):42-6.
• Schein OD, Rosenthal P, Ducharme C. A gas-permeable scleral contact lens for visual rehabilitation. Am J Ophthalmol. 1990 Mar 15;109(3):318-22.
• Rosenthal, P. The Boston Lens and the management of keratoconus. Int Ophthalmol Clin. 1986 Spring;26(1):101-9.